Vanderbilt University Medical Center (VUMC) and the NCI-designated Vanderbilt-lngram Comprehensive Cancer Center (VICC) have taken specific actions to improve the quantity and quality of opportunities for training in translational research available to translational/clinical investigators, laboratory-based physician-scientists and basic scientists. These actions are of vital importance for the success of the Breast SPORE as well as for the successful application of progress made in the laboratory to our ultimate goal: a reduction in the incidence, morbidity and mortality resulting from breast cancer. To achieve these overall goals, the SPORE includes a Career Development Program (CDP).
Specific aims of the CDP are as follows: To recruit, support and develop young physician-scientists and laboratory-based translational/clinical investigators (MD and MD/PhD) into breast cancer research To recruit, support and develop young basic scientists (PhD) into mechanism-based applied research in breast cancer To recruit outstanding basic scientists into breast cancer research and provide clinical and translational expertise to this research To provide translational research mentorship, training and opportunities for investigators to develop the knowledge, skills and expertise to successfully pursue independent, extramurally-funded scholarly careers focused in translational research in breast cancer To make a high priority the recruitment of women and underrepresented minority investigators into research in breast cancer

Public Health Relevance

The CDP has two complementary tracks: a physician-scientist/translational investigator (MD and MD/PhD) track and a basic scientist (PhD) track. For the first track, the Breast SPORE has built upon a successful NIH-funded training program: the Vanderbilt Physician Scientist Development (VPSD) Program. The second track of the CDP is for early, mid-career or senior basic scientists (PhDs) who wish to focus their research in breast cancer. We strongly believe that this dual pathway is highly relevant and important in order to recruit the best institutional talent into research domains that can eventually lead to progress in breast cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-0)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
United States
Zip Code
Bhola, Neil E; Jansen, Valerie M; Bafna, Sangeeta et al. (2015) Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer. Cancer Res 75:405-14
Sanders, Melinda E; Schuyler, Peggy A; Simpson, Jean F et al. (2015) Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol 28:662-9
Abramson, Vandana G; Lehmann, Brian D; Ballinger, Tarah J et al. (2015) Subtyping of triple-negative breast cancer: implications for therapy. Cancer 121:16-Aug
Guo, Yan; Zhao, Shilin; Lehmann, Brian D et al. (2014) Detection of internal exon deletion with exon Del. BMC Bioinformatics 15:332
Barnes, Stephanie L; Quarles, C Chad; Yankeelov, Thomas E (2014) Modeling the effect of intra-voxel diffusion of contrast agent on the quantitative analysis of dynamic contrast enhanced magnetic resonance imaging. PLoS One 9:e108726
Grieb, Brian C; Chen, Xi; Eischen, Christine M (2014) MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival. Mol Cancer Res 12:1216-24
Su, Pei-Fang; Li, Chung-I; Shyr, Yu (2014) Sample size determination for paired right-censored data based on the difference of Kaplan-Meier estimates. Comput Stat Data Anal 74:39-51
Bi, Xiaohong; Rexer, Brent; Arteaga, Carlos L et al. (2014) Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy. J Biomed Opt 19:025001
Jiang, Junfeng; Jia, Peilin; Shen, Bairong et al. (2014) Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites. Oncotarget 5:6168-77
Jiang, Junfeng; Jia, Peilin; Zhao, Zhongming et al. (2014) Key regulators in prostate cancer identified by co-expression module analysis. BMC Genomics 15:1015

Showing the most recent 10 out of 195 publications